a month ago
LEGN
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 12%
#507 out of 4233 analysts
Average Return
+10.19%
Win Rate
50%24 out of 48
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-25 - 2020-06-10 | Strong Buy |
Ascendis Pharma AASND | +134.77% | $27.90 | $65.50 | 2017-05-10 - 2018-05-11 | Strong Buy |
Nektar TherapeuticsNKTR | +88.09% | $4.87 | $0.58 | 2022-08-07 - 2023-05-31 | Strong Sell |
Tricida IncTCDAQ | +80.43% | $0.55 | $0.11 | 2022-10-24 - 2023-01-23 | Strong Sell |
United Therapeutics CorpUTHR | +67.73% | $97.67 | $163.82 | 2020-01-30 - 2021-01-29 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
6 months ago
LEGN
7 months ago
VRTX
7 months ago
MRNA
9 months ago
IMCR
a year ago
UTHR
a year ago
CARA
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alkermes PLCALKS | 2 | Hold | $31.00 | +7.16% | Maintains | a month ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $76.00 | +18.44% | Maintains | a month ago |
Moderna IncMRNA | 4 | Hold | $140.00 | +9.62% | Maintains | 2 months ago |
Biontech SeBNTX | 3 | Hold | $128.00 | +21.81% | Maintains | 2 months ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $29.00 | -11.04% | Downgrades | 3 months ago |
Novocure LtdNVCR | 2 | Strong Sell | $50.00 | -30.37% | Downgrades | 3 months ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | +5.51% | Downgrades | 3 months ago |
Intra Cellular Therapies IncITCI | 2 | Strong Buy | $58.00 | -2.32% | Maintains | 3 months ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | +561.76% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 3 | Strong Buy | $52.00 | +60.35% | Maintains | 3 months ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | -23.35% | Maintains | 4 months ago |
Incyte CorpINCY | 2 | Hold | $80.00 | +29.98% | Maintains | 4 months ago |
United Therapeutics CorpUTHR | 5 | Strong Buy | $265.00 | +26.35% | Maintains | 7 months ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 7 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $327.00 | +1.06% | Maintains | 7 months ago |
Biomarin Pharmaceutical IncBMRN | 1 | Strong Buy | $112.00 | +28.82% | Maintains | 7 months ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $200.00 | +8.10% | Maintains | 7 months ago |
Immunocore Holdings PLCIMCR | 1 | Strong Buy | $67.00 | +21.42% | Maintains | 9 months ago |
Nektar TherapeuticsNKTR | 2 | Strong Sell | N/A | N/A | Downgrades | 10 months ago |
Amarin Corp PLCAMRN | 1 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Cara Therapeutics IncCARA | 2 | Strong Buy | $20.00 | N/A | Upgrades | a year ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | a year ago |
Insmed IncINSM | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $41.00 | N/A | Upgrades | 2 years ago |
Mirum Pharmaceuticals IncMIRM | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Magenta Therapeutics IncMGTA | 1 | Hold | $7.00 | N/A | Downgrades | 2 years ago |
Axcella Health IncAXLA | 1 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $28.00 | N/A | Upgrades | 2 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 2 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 3 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 4 years ago |
Mersana Therapeutics IncMRSN | 4 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 5 years ago |
Radius Health IncRDUS | 4 | Strong Buy | $52.00 | N/A | Maintains | 5 years ago |
Deciphera Pharmaceuticals IncDCPH | 2 | Strong Buy | $33.00 | N/A | Maintains | 5 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Denali Therapeutics IncDNLI | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Advanced Accelerator Applications SaAAAP | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Ascendis Pharma AASND | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.